⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 18, 2026JAMA

Toward Greater Transparency at the FDA—Now Is the Time to Act

Irene Park Ulrich Peter Lurie

View at Publisher

Ask AI

Bookmark

Share

Key Points

The aim is to assess and improve the FDA's transparency in its regulatory processes.
Analyzed the FDA's current transparency practices and policies.
Identified gaps and challenges in the existing framework.
Established recommendations for enhanced transparency measures.
Highlighted the need for improved communication with the public.
Emphasized the importance of transparency in building public trust.
Called for immediate action to implement transparency initiatives.

Implication

This viewpoint urges increased transparency at the FDA, indicating its importance for public trust and accountability.

Abstract

This Viewpoint considers the US Food and Drug Administration’s track record for transparency and urges the agency to fortify transparency efforts.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ulrich et al. (2026) studied this question.

synapsesocial.com/papers/69be36416e48c4981c6750bc https://doi.org/10.1001/jama.2026.1652

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Transparency at the Food and Drug AdministrationOriginal Research · 2010 · 37 citations
2Never Waste a Crisis: The Past, Present, and Future of FDA Reform2025
3Making the FDA Great AgainOriginal Research · 2026 · 1 citations
4US Food and Drug Administration Officials’ Public Statements on Regulatory Flexibility in New Drug Approval, 2021–2024Original Research · 2026
5Law, Politics, and Expert Panels at the US Food and Drug AdministrationOriginal Research · 2026 · 1 citations

More related papers

Analysis calls for transparency in FDA reporting of trials2026
Tear down the wall: why requiring the FDA and the PTO to share information will improve the decision-making of both agencies2026
Whose Burden Is It Anyway? A Comprehensive Proposal to Reshape Food Safety Review by Treating Food as Medicine2025

More from JAMA

Revascularization in Asymptomatic Carotid Artery Stenosis With Hemodynamic Impairment and Cognitive OutcomesWed,
Intrauterine Mepivacaine Instillation vs Placebo for Pain During IUD PlacementThu,